Welcome address: P Youinou

October 1, 2009 - Thursday morning

ETIOLOGY Chair : S Krillis  (Australia), JO Pers (France), and T Dörner (Germany)

• Virus or viruses in terms of pathophysiology?  HM Moutsopoulos (Greece)
• Are infections pathogenic and/or protective autoimmune disorders? Y Shoenfeld (Israël)
• Genetic basis of Sjögren's syndrome : JM Anaya (Colombia)
• Epigenetics : S Gay (Switzerland)
• Toll-like receptors in Sjögren's syndrome Th Defrance (France)
• Sex hormones : YT Konttinen (Finland)

Discussion, debate and synthesis

Coffee break

Six oral communications - Chair : G Steiner (Austria), V Devauchelle (France), and A Parke (USA)


Thursday afternoon

Guided visit of the posters : S Hillion (France), S Bowman (UK), and PY Hatron (France)

CLINICS & BIOLOGY Chair : Y Shoenfeld (Israël), S Sawada (Japan) and M Ramos-Casals (Spain)

• For debate : The IgG4 syndrome, pro and con : H Takahashi (Japan)
• The impact of Sjögren's on the cornea : C Baudouin (France)
• Periodontitis, a model for autoimmunity, the way to Sjögren's syndrome? N Moutsopoulos (USA)
• Complications besides oral and ocular symptoms : C Kallenberg (The Netherlands)
• Proteomics : GF Ferraccioli (Italy)

Coffee break

October 2, 2009 - Friday morning

PATHOPHYSIOLOGY Chair : HM Moutsopoulos (Greece), S Gay (Switzerland), and Th Defrance (France)

• The enigma of memory B lymphocytes : PE Lipsky (NIH)
• Primary biliary cirrhosis: a model for Sjögren's? : E Gershwin (USA)
• The cytotoxic T, Treg, Th17, Th1 and Th2 cell ballet : R Jonsson (Norway)
• BAFF, the conductor of the Sjögren's orchestra : F Mackay (Australia)
• Aberrant chemokine production and ectopic lymphoneogenesis : C Pitzalis (UK)

Coffee break

Six oral communications - Chair : C Pitzalis (UK), C Jamin (France), and R Levy (Brazil)

Friday afternoon

Guided visit of the posters : R Jonsson (Norway), S Jousse (France), and S Gay (Switzerland)

TREATMENT Chair : P Lipsky (USA), A Dinç (Turkey), and G Valesini (Italy)

• Reappraisal of conventional therapy. DA Isenberg (UK)
• Further insights into B cell-depletion. T Dörner (Germany)
• Biotherapies other than anti-CD20. R Eisenberg (USA)
• The point on ongoing rituximab trials over the world. A Saraux (France)
  

Coffee break

Six oral communications - Chair : Ph Cohen (USA), Q Lu (China), and L Guillevin (France)

October 3, 2009 - Saturday morning

EPIDEMIOLOGY Chair : S Sugai (Japan), R Manthorpe (Sweden), and DA Isenberg (UK)

• Reappraisal of past studies in epidemiology. S Bombardieri (Italy)
• Lymphoid malignancies: who? why? when? and where X Mariette (France)
• The natural history of Sjögren's syndrome. T Daniels (USA)
• The difficulties to assess disease activity. C Vitali (Italy)
• How to improve the quality of life of patients with Sjögren's syndrome. S Bowman (UK)
  

Coffee break

Four oral communications - Chair : R Eisenberg (USA), JO Pers (France), and A Tzioufas (Greece)

Take-home messages and announcement of the next symposium. A Saraux